|
1
|
Friedenstein AJ, Chailakhyan RK and
Gerasimov UV: Bone marrow osteogenic stem cells: In vitro
cultivation and transplantation in diffusion chambers. Cell Tissue
Kinet. 20:263–272. 1987.PubMed/NCBI
|
|
2
|
Lv FJ, Tuan RS, Cheung KM and Leung VY:
Concise review: The surface markers and identity of human
mesenchymal stem cells. Stem Cells. 32:1408–1419. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop D and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grégoire C, Lechanteur C, Briquet A,
Baudoux É, Baron F, Louis E and Beguin Y: Review article:
Mesenchymal stromal cell therapy for inflammatory bowel diseases.
Aliment Pharmacol Ther. 45:205–221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Le Blanc K, Tammik C, Rosendahl K,
Zetterberg E and Ringdén O: HLA expression and immunologic
properties of differentiated and undifferentiated mesenchymal stem
cells. Exp Hematol. 31:890–896. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee MW, Kim DS, Yoo KH, Kim HR, Jang IK,
Lee JH, Kim SY, Son MH, Lee SH, Jung HL, et al: Human bone
marrow-derived mesenchymal stem cell gene expression patterns vary
with culture conditions. Blood Res. 48:107–114. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mounayar M, Kefaloyianni E, Smith B,
Solhjou Z, Maarouf OH, Azzi J, Chabtini L, Fiorina P, Kraus M,
Briddell R, et al: PI3kα and STAT1 interplay regulates human
mesenchymal stem cell immune polarization. Stem Cells.
33:1892–1901. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang G, Zhang S, Wang F, Li G, Zhang L and
Luan X: Expression and biological function of programmed death
ligands in human placenta mesenchymal stem cells. Cell Biol Int.
37:137–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan Z, Zhuansun Y, Liu G, Chen R, Li J and
Ran P: Mesenchymal stem cells suppress T cells by inducing
apoptosis and through PD-1/B7-H1 interactions. Immunol Lett.
162:248–255. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tipnis S, Viswanathan C and Majumdar AS:
Immunosuppressive properties of human umbilical cord-derived
mesenchymal stem cells: Role of B7-H1 and IDO. Immunol Cell Biol.
88:795–806. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jang IK, Yoon HH, Yang MS, Lee JE, Lee DH,
Lee MW, Kim DS and Park JE: B7-H1 inhibits T cell proliferation
through MHC class II in human mesenchymal stem cells. Transplant
Proc. 46:1638–1641. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Croitoru-Lamoury J, Lamoury FM, Caristo M,
Suzuki K, Walker D, Takikawa O, Taylor R and Brew BJ: Interferon-γ
regulates the proliferation and differentiation of mesenchymal stem
cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS
One. 6:e146982011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zaidi MR and Merlino G: The two faces of
interferon-γ in cancer. Clin Cancer Res. 17:6118–6124. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee MW, Choi J, Yang MS, Moon YJ, Park JS,
Kim HC and Kim YJ: Mesenchymal stem cells from cryopreserved human
umbilical cord blood. Biochem Biophys Res Commun. 320:273–278.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jang IK, Ahn JI, Shin JS, Kwon YS, Ryu YH,
Lee JK, Park JK, Song KY, Yang EK and Kim JC: Transplantation of
reconstructed corneal layer composed of corneal epithelium and
fibroblasts on a lyophilized amniotic membrane to severely
alkali-burned cornea. Artif Organs. 30:424–431. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim N, Im KI, Lim JY, Jeon EJ, Nam YS, Kim
EJ and Cho SG: Mesenchymal stem cells for the treatment and
prevention of graft-versus-host disease: Experiments and practice.
Ann Hematol. 92:1295–1308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chinnadurai R, Copland IB, Patel SR and
Galipeau J: IDO-independent suppression of T cell effector function
by IFN-γ-licensed human mesenchymal stromal cells. J Immunol.
192:1491–1501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ritprajak P and Azuma M: Intrinsic and
extrinsic control of expression of the immunoregulatory molecule
PD-L1 in epithelial cells and squamous cell carcinoma. Oral Oncol.
51:221–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liotta F, Querci V, Mannelli G,
Santarlasci V, Maggi L, Capone M, Rossi MC, Mazzoni A, Cosmi L,
Romagnani S, et al: Mesenchymal stem cells are enriched in head
neck squamous cell carcinoma, correlates with tumour size and
inhibit T-cell proliferation. Br J Cancer. 112:745–754. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shou P, Chen Q, Jiang J, Xu C, Zhang J,
Zheng C, Jiang M, Velletri T, Cao W, Huang Y, et al: Type I
interferons exert anti-tumor effect via reversing immunosuppression
mediated by mesenchymal stromal cells. Oncogene. 35:5953–5962.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carbotti G, Barisione G, Airoldi I,
Mezzanzanica D, Bagnoli M, Ferrero S, Petretto A, Fabbi M and
Ferrini S: IL-27 induces the expression of IDO and PD-L1 in human
cancer cells. Oncotarget. 6:43267–43280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seo SK, Seo DI, Park WS, Jung WK, Lee DS,
Park SG, Choi JS, Kang MS, Choi YH, Choi I, et al: Attenuation of
IFN-γ-induced B7-H1 expression by
15-deoxy-delta(12,14)-prostaglandin J2 via downregulation of the
Jak/STAT/IRF-1 signaling pathway. Life Sci. 112:82–89. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Burand AJ, Gramlich OW, Brown AJ and
Ankrum JA: Function of cryopreserved mesenchymal stromal cells with
and without interferon-γ prelicensing is context dependent. Stem
Cells. 35:1437–1439. 2017. View Article : Google Scholar : PubMed/NCBI
|
